These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

152 related items for PubMed ID: 31366755

  • 1. [Successful treatment of severe sulfonylurea-induced hypoglycemia by the subcutaneous administration of octreotide in an elderly patient with diabetes: A case report].
    Nakaya M, Oka R, Miyamoto S.
    Nihon Ronen Igakkai Zasshi; 2019; 56(3):336-342. PubMed ID: 31366755
    [Abstract] [Full Text] [Related]

  • 2. Safety of subcutaneous octreotide in patients with sulfonylurea-induced hypoglycemia and congestive heart failure.
    Vallurupalli S.
    Ann Pharmacother; 2010 Feb; 44(2):387-90. PubMed ID: 20118140
    [Abstract] [Full Text] [Related]

  • 3. Successful treatment of sulfonylurea-induced prolonged hypoglycemia with use of octreotide.
    Fleseriu M, Skugor M, Chinnappa P, Siraj ES.
    Endocr Pract; 2006 Feb; 12(6):635-40. PubMed ID: 17229659
    [Abstract] [Full Text] [Related]

  • 4. Octreotide for the treatment of sulfonylurea poisoning.
    Glatstein M, Scolnik D, Bentur Y.
    Clin Toxicol (Phila); 2012 Nov; 50(9):795-804. PubMed ID: 23046209
    [Abstract] [Full Text] [Related]

  • 5. [Role of octreotide in the treatment of hypoglycemia induced by sulfonylureas].
    Clerc D, Hugli O, Trueb L, Yersin B.
    Rev Med Suisse; 2008 Aug 20; 4(167):1764-7. PubMed ID: 18800755
    [Abstract] [Full Text] [Related]

  • 6. Octreotide for hypoglycemia caused by sulfonylurea and DPP-4 inhibitor.
    Yamaguchi S, Ikejima M, Furukawa A, Abe M, Nakazaki M, Ishihara H.
    Diabetes Res Clin Pract; 2015 Aug 20; 109(2):e8-e10. PubMed ID: 26025695
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Octreotide treatment for sulfonylurea-induced hypoglycaemia.
    Crawford BA, Perera C.
    Med J Aust; 2004 May 17; 180(10):540-1; author reply 541. PubMed ID: 15139835
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Continuous octreotide infusion for sulfonylurea-induced hypoglycemia in a toddler.
    Llamado R, Czaja A, Stence N, Davidson J.
    J Emerg Med; 2013 Dec 17; 45(6):e209-13. PubMed ID: 23827165
    [Abstract] [Full Text] [Related]

  • 16. A prospective trial of risk factors for sulfonylurea-induced hypoglycemia in type 2 diabetes mellitus.
    Burge MR, Schmitz-Fiorentino K, Fischette C, Qualls CR, Schade DS.
    JAMA; 1998 Jan 14; 279(2):137-43. PubMed ID: 9440664
    [Abstract] [Full Text] [Related]

  • 17. Comparison of octreotide and standard therapy versus standard therapy alone for the treatment of sulfonylurea-induced hypoglycemia.
    Francis M, Langhan T, Prosser J, Hoffman R.
    Ann Emerg Med; 2008 Jun 14; 51(6):795-6; author reply 796-7. PubMed ID: 18489980
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [A case of hypoglycemia caused by the accidental ingestion of glimepiride in an elderly dementia patient diagnosed based on the serum glimepiride concentration].
    Fujieda N, Hazekawa I, Araki E.
    Nihon Ronen Igakkai Zasshi; 2013 Jun 14; 50(4):550-4. PubMed ID: 24047673
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.